Avenue Therapeutics, Inc. (ATXI) Social Stream

Avenue Therapeutics, Inc. (ATXI): $1.13

0.01 (+0.54%)

POWR Rating

Component Grades








Add ATXI to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




#163 of 168

in industry

AVENUE THERAPEUTICS INC (ATXI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ATXI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-04-03 1 $32 $32 $32 $1.11 2782.88%
NA 1 $NA $NA $NA $1.11 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target

ATXI's average price target has moved up $23 over the prior 24 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-03 1 32 32 32 1.18 2611.86%

ATXI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ATXI has a greater number of analysts covering the stock than nearly none of all US stocks.
  • In the context of all US stocks, AVENUE THERAPEUTICS INC's variance in analysts' estimates is lower than almost 100% of them.
  • In terms of how AVENUE THERAPEUTICS INC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is greater than 97.57% of that group.
  • AVENUE THERAPEUTICS INC's average analyst price target is higher than 92.01% of stocks in the micro market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AVENUE THERAPEUTICS INC are LPTX, PULM, and APVO.

Is ATXI a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8437 seconds.